全、新、优、品、好四大特点：

磷酸化细胞核因子p50/k基因结合核因子抗体说明书 全：公司提供上万种产品，涵盖了生物试剂，elisa试剂盒，标准品，培养基，原装耗材，抗体、培养基、ATCC细胞等，基本上各种科研所需产品在我司都能找到。

新：产品更新速度较快，基本上每周都有新产品出现。

优：产品质量好，投诉比较少。

好：我公司具有优质的技术团队，产品一旦售出，实验过程中遇到困难可提供在线技术咨询。使您使用产品时没有任何的后顾之忧。

磷酸化细胞核因子p50/k基因结合核因子抗体说明书 英文名称  Anti-Phospho-NFKB1(Ser932)

中文名称  磷酸化细胞核因子p50/k基因结合核因子抗体说明书 

别    名 DKFZp686C01211; DNA binding factor KBF1; DNA binding factor KBF1 EBP1; DNA binding factor KBF1 EBP1; DNA-binding factor KBF1; EBP 1; EBP-1; EBP1; KBF1; MGC54151; NF kappa B; NF kappabeta; NF kB1; NFKB 1; NFKB p105; NFKB p50; NFKB1; NFKB1_HUMAN; Nuclear factor kappa B DNA binding subunit; Nuclear factor NF kappa B p105 subunit; Nuclear factor NF kappa B p50 subunit; Nuclear factor NF-kappa-B p50 subunit; Nuclear factor of kappa light polypeptide gene enhancer in B cells 1; Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; p84/NF-kappa-B1 p98.

产品属性：

浓    度  1mg/1ml

规 格  0.1ml/100μg

抗体来源  Rabbit

克隆类型   polyclonal

交叉反应   Human, Mouse, Rat, Chicken, Dog, Pig, Cow

产品类型   一抗 磷酸化抗体  

研究领域     细胞生物 免疫学 染色质和核信号 信号转导 细胞凋亡 转录调节因子 表观遗传学

蛋白分子量  predicted molecular weight: 48/105kDa 

性    状   Lyophilized or Liquid

免 疫 原  KLH conjugated Synthesised phosphopeptide derived from human NF KappaB p105 around the phosphorylation site of Ser932 [ET(p-S)FR]

亚    型  IgG

纯化方法   affinity purified by Protein A

储 存 液   0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide

磷酸化细胞核因子p50/k基因结合核因子抗体说明书 产品应用   WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蜡切片需做抗原修复） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存条件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

产品介绍 This gene encodes a 105 kD protein which can undergo cotranslational processing by the 26S proteasome to produce a 50 kD protein. The 105 kD protein is a Rel protein-specific transcription inhibitor and the 50 kD protein is a DNA binding subunit of the NF-kappa-B (NFKB) protein complex. NFKB is a transcription regulator that is activated by various intra- and extra-cellular stimuli such as cytokines, oxidant-free radicals, ultraviolet irradiation, and bacterial or viral products. Activated NFKB translocates into the nucleus and stimulates the expression of genes involved in a wide variety of biological functions. Inappropriate activation of NFKB has been associated with a number of inflammatory diseases while persistent inhibition of NFKB leads to inappropriate immune cell development or delayed cell growth. SUBUNIT: Active NF-kappa-B is a heterodimer of an about 50 kDa DNA-binding subunit and the weak DNA-binding subunit p65. Two heterodimers might form a labile tetramer. Also interacts with MAP3K8. NF-kappa-B p50 subunit interacts with NCOA3 coactivator, which may coactivate NF-kappa-B dependent expression via its histone acetyltransferase activity. Interacts with DSIPI; this interaction prevents nuclear translocation and DNA-binding. Interacts with SPAG9 and UNC5CL.

Function : NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric p65-p50 and RelB-p50 complexes are transcriptional activators. The NF-kappa-B p50-p50 homodimer is a transcriptional repressor, but can act as a transcriptional activator when associated with BCL3. NFKB1 appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins by p105 and generation of p50 by a cotranslational processing. The proteasome-mediated process ensures the production of both p50 and p105 and preserves their independent function, although processing of NFKB1/p105 also appears to occur post-translationally. p50 binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions. In a complex with MAP3K8, NFKB1/p105 represses MAP3K8-induced MAPK signaling; active MAP3K8 is released by proteasome-dependent degradation of NFKB1/p105.Subunit : Component of the NF-kappa-B p65-p50 complex. Component of the NF-kappa-B p65-p50 complex. Homodimer; component of the NF-kappa-B p50-p50 complex. Component of the NF-kappa-B p105-p50 complex. Component of the NF-kappa-B p50-c-Rel complex. Component of a complex consisting of the NF-kappa-B p50-p50 homodimer and BCL3. Also interacts with MAP3K8. NF-kappa-B p50 subunit interacts with NCOA3 coactivator, which may coactivate NF-kappa-B dependent expression via its histone acetyltransferase activity. Interacts with DSIPI; this interaction prevents nuclear translocation and DNA-binding. Interacts with SPAG9 and UNC5CL. NFKB1/p105 interacts with CFLAR; the interaction inhibits p105 processing into p50. NFKB1/p105 forms a ternary complex with MAP3K8 and TNIP2. Interacts with GSK3B; the interaction prevents processing of p105 to p50. NFKB1/p50 interacts with NFKBIE. NFKB1/p50 interacts with NFKBIZ. Nuclear factor NF-kappa-B p50 subunit interacts with NFKBID. Directly interacts with MEN1. Interacts with HIF1AN.Subcellular Location : Nucleus. Cytoplasm. Note=Nuclear, but also found in the cytoplasm in an inactive form complexed to an inhibitor (I-kappa-B).Post-translational modifications : While translation occurs, the particular unfolded structure after the GRR repeat promotes the generation of p50 making it an acceptable substrate for the proteasome. This process is known as cotranslational processing. The processed form is active and the unprocessed form acts as an inhibitor (I kappa B-like), being able to form cytosolic complexes with NF-kappa B, trapping it in the cytoplasm. Complete folding of the region downstream of the GRR repeat precludes processing.Phosphorylation at 'Ser-903' and 'Ser-907' primes p105 for proteolytic processing in response to TNF-alpha stimulation. Phosphorylation at 'Ser-927' and 'Ser-932' are required for BTRC/BTRCP-mediated proteolysis.Polyubiquitination seems to allow p105 processing.S-nitrosylation of Cys-61 affects DNA binding.The covalent modification of cysteine by 15-deoxy-Delta12,14-prostaglandin-J2 is autocatalytic and reversible. It may occur as an alternative to other cysteine modifications, such as S-nitrosylation and S-palmitoylation.Similarity : Contains 7 ANK repeats.Contains 1 death domain.Contains 1 RHD (Rel-like) domain.Database links : UniProtKB/Swiss-Prot: P19838.2

实验流程：

正在热销的相关产品：

anti-CIB1/FITC 荧光素标记钙-整合素结合蛋白1抗体IgGMulti-class antibodies规格： 0.2ml

Anti-Inhibin BetaA/FITC 荧光素标记抑制素βA抗体IgGMulti-class antibodies规格： 0.2ml

Rhesus antibody Rh CCR8 细胞表面趋化因子受体8抗体 规格 0.1ml

Integrin AlphaE2/CD103 整合素αE2抗原 0.2ml

phospho-IRS1(Ser332 + Ser336) 英文名称： 磷酸化受体底物-1抗体 0.1ml

Rhesus antibody Rh SPON2/M spondin/Mindin 细胞外基质底物反应蛋白2抗体 规格 0.2ml

Anti-Inhibin BetaA/FITC 荧光素标记抑制素βA抗体IgGMulti-class antibodies规格： 0.2ml

eNOS(Mouse Endothelial nitric oxide synthase) ELISA Kit 小鼠内皮型合成酶Multi-class antibodies规格： 48T

Anti-CD105/Endoglin/TGF- Beta receptor/FITC 荧光素标记CD105/转化生长因子β受体抗体IgGMulti-class antibodies规格： 0.2ml

Rhesus antibody Rh Donkey Anti-rabbit IgG/PE PE标记的驴抗兔IgG 规格 0.1ml

AFP 甲胎蛋白定性 96T

MTMR14 英文名称： 肌管素相关蛋白14抗体 0.2ml

ABHD3 英文名称： 肺α/β水解酶蛋白3抗体 0.2ml

Anti-CD105/Endoglin/TGF- Beta receptor/FITC 荧光素标记CD105/转化生长因子β受体抗体IgGMulti-class antibodies规格： 0.2ml

MPO(Human myeloperoxidase) ELISA Kit 人髓过氧化物酶Multi-class antibodies规格： 48T

Anti-NRSF/REST 神经元抑制蛋白抗体Multi-class antibodies规格： 0.2ml

Rhesus antibody Rh IFNGR1/CD119 干扰素-gamma受体1抗体 规格 0.1ml

IL-27(Mouse Interleukin 27)ELISA Kit 小鼠白介素27 96T

p70 S6 kinase alpha 英文名称： 核糖体p70 S6蛋白激酶抗体 0.1ml

C3orf37 英文名称： 3号染色体开放阅读框37抗体 0.2ml

Anti-NRSF/REST 神经元抑制蛋白抗体Multi-class antibodies规格： 0.2ml

溴紫葡萄糖琼脂250g用于嗜热需氧芽孢杆菌计数

L-BacterialHypertonicSaltBroth

M17琼脂 M17 Agar 250 用于牛奶和乳制品中乳酸菌检测和分离培养(Merck方法)

含0.6%酵母浸膏的胰酪胨大豆琼脂(TSA-YE)250g/瓶用于李斯特氏菌纯化incubationmedia含0.6%酵母浸膏的胰酪胨大豆琼脂(TSA-YE)250g/瓶用于李斯特氏菌纯化

StrainStoreMedium

盐增菌液(SF)23050250g用于沙门氏菌特别是伤寒沙门氏菌的选择性分离培养(GB4789.4-20/T2206.8和SN02...

加强梭状芽孢杆菌培养基 (RCM) (semi-solid) (CM0149) Oxoid incubation media 加强梭状芽孢杆菌培养基 (RCM) (semi-solid) (CM0149) Oxoid

球毛壳 防治鞘翅目、同翅目的幼虫及成虫。 支/瓶

WaterPlateCountAgar

沙氏葡萄糖琼脂(SDA) 250g 用于真菌的分离培养

磷酸化细胞核因子p50/k基因结合核因子抗体说明书 冻干血浆 0.5mL/支×10(g)  incubation media 冻干血浆 0.5mL/支×10(g)

DNA酶琼脂 100(g)  incubation media DNA酶琼脂 100(g)

7.5%肉汤 250(g)  incubation media 7.5%肉汤 250(g)

7.5%肉汤 1000(g)  incubation media 7.5%肉汤 1000(g)

技术外包服务:

★磷酸化细胞核因子p50/k基因结合核因子抗体说明书 分子生物学：质粒抽提、PCR、Q-PCR、RT-PCR、分子生物学：基因合成、引物合成、基因测序、载体构建等

★蛋白工程：原核、哺乳动物蛋白表达系统等

★病毒包装：腺病毒、慢病毒等

★抗体工程：磁珠分选、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等

★细胞工程：细胞表型分析(凋亡、增殖、周期、迁移、侵袭、修复、克隆形成)、细胞培养、细胞膜制备、稳定细胞株构建、细胞RNAi技术等等。